A semaglutide starting price can mean a complete compounded supply, a first-month discount or the monthly equivalent of a year paid upfront. Those are different financial decisions. This index records seven named offers with the payment conditions that make the numbers useful.
Injection Index does not assign a universal cheapest provider from incomplete quantities or different formulations. The current official captures distinguish recurring prices, promotions and annual commitments. A compounded preparation remains different from FDA-approved branded semaglutide, and the clinician should explain why the actual prescription is appropriate.
Update ·
Find the lowest complete bill for the same period
Begin with the amount collected today, not the largest price printed on a card. Write down the exact product, supplied amount and duration that collection buys. Keep a four-week supply identified as four weeks. If an offer is described by a monthly equivalent, add the actual advance payment and term before comparing it with a recurring charge.
Next, copy the first renewal amount and its date from the selected quote. Put any introductory eligibility rule beside the first collection so it cannot silently become the regular price in your budget. When supply duration and billing frequency differ, use two lines: what arrives and when payment is taken. An unknown quantity or renewal is a reason to request a quote, not a zero-cost entry.
Build the total from separate categories: medication, membership, consultation, laboratory work, supplies and delivery. Mark each as included, separately priced or unresolved. Do not add a charge twice because two descriptions name the same service, and do not assume an omitted charge is included.
Only then compare complete totals over one shared period. Keep product differences visible and use the comparison to answer a financial question; the lowest headline does not determine an individual prescription. Recheck the selected agreement when the dose, supply or term changes.
Semaglutide $948/year ($79/mo equivalent) or $139 month-to-month; tirzepatide terms differ
Likeness Rx offers compounded semaglutide and tirzepatide with explicit term pricing. Its lowest advertised monthly equivalents are $79 and $129 on annual prepaid terms; month-to-month options cost more.
GLP-1 from $89; GLP-1 plus GIP from $149; selected preparation and terms apply
AltRx’s low starting GLP-1 rate sits alongside different compounded and branded offers; paid testimonials and complete plan terms need their own reading.
Trimi explicitly separates an annual monthly equivalent from the upfront bill: semaglutide is advertised at $1,188 for twelve months, with a different month-to-month rate.
Confirm the exact preparation, renewal, supplied amount, pharmacy, and clinical follow-up for the chosen order.
The details, visualized
Cheapest semaglutide injection plans — offer map
A practical decision map; not a clinical score
CoreAge Rx$79/mo
Keep the exact product destination and selected agreement with your quote; consult the dated CoreAge Rx update for the source-status distinction.
SuperHealthy Rx$85/mo semaglutide offer
The dedicated promotion quotes two medicine-specific rates and describes what is included; the broader homepage is a different offer context.
Likeness RxFrom $79/mo equivalent
The lowest monthly equivalent requires the longest prepaid term. The page makes the amount due for each term visible.
SnagRx$69/mo
SnagRx’s promotion names both medicines and says visits, supplies and shipping are included. Confirm the chosen order’s full term before relying on the headline.
AltRx$89/mo
AltRx’s promotional starting rate is clear, but the exact preparation, renewal and pharmacy still belong in the selected order.
Enhance.MD$112 start
Identify the medicine, supply period and renewal in the selected quote.
Trimi$99/mo equiv.
Trimi explicitly distinguishes an annual upfront charge from month-to-month pricing for both medicines.
Use the source documents and your selected agreement. A public description does not determine personal treatment eligibility.
The offers here are selected public examples, not an exhaustive market census or a guarantee of the lowest available price. Some require a longer term; others advertise a promotion with selected checkout conditions. The chart shows those terms alongside each figure so a low equivalent does not hide a large first payment.
A useful shortlist should survive three checks: the actual product matches the comparison, the current checkout supports the advertised rate, and the renewal fits the budget. If any of those details is unknown, obtain a quote before treating the entry as the cheapest purchase.
Before you decide
Questions worth answering
Does the order on this page identify the best treatment for me?
No. It is a publisher-arranged comparison of selected public offers. The chart explains the specific purchase or evidence question; a licensed clinician must assess the actual treatment.
What should I verify for this comparison?
Compare semaglutide entry prices only after exposing each plan’s commitment and inclusion rules. Ask for the selected written quote and the product-specific clinical explanation before making a purchase.
Evidence behind this page
Sources & chart notes
Source dates are listed with each document. Earlier research and later offer updates are identified separately. Provider pages establish advertised terms. Labels and trial reports describe specific medicines and study populations. Medical review has not been completed.
Cheapest semaglutide injection plans: offers with the whole bill visible — compare what the payment covers, when it renews and which charges remain separate.
What makes this shortlist useful
Compare the selected semaglutide preparation, prescribed amount, supply duration and total payment. Keep four weeks separate from a calendar month, and do not treat an annual equivalent as a monthly charge. Consultation, supplies and delivery need their own confirmation where inclusion is unclear. The useful question is what the patient will actually pay now and at renewal. Read the related care guide for a wider treatment discussion.
What makes this shortlist useful — keep the exact product identity and its complete label together.
1. CoreAge Rx: a stated monthly compounded offer
CoreAge provides clinician assessment and a compounded injection pathway with a stated ingredient-specific starting rate. Its product pages separate semaglutide from tirzepatide. The prescription, concentration and amount dispensed should be confirmed rather than inferred from the price or transferred from another provider’s vial instructions. The named semaglutide page provides a clear starting rate and no-membership claim. The actual dispensed amount and repeat-order terms still need confirmation before it becomes a like-for-like price comparison.
CoreAge’s linked promotion advertises compounded semaglutide at $79 per month and tirzepatide at $129. Read the dated CoreAge Rx update before using a main-product price; retain the selected offer and confirm the commitment and amount due. Confirm the actual amount, billing interval and dispensing pharmacy. Its refund policy has pharmacy-approval and elapsed-time limits; cancellation should not be assumed to refund a prepared prescription.
SuperHealthy Rx advertises compounded semaglutide from $85/month and tirzepatide from $135/month. The linked offer says the provider visit and shipping are included. Confirm the amount due, plan term and refill settings; a prescription depends on clinician review. These are published service terms, not independently tested outcomes. Read the SuperHealthy Rx review.
SuperHealthy Rx: compare the selected agreement with the questions in this section.
3. Likeness Rx — GLP-1 weight care
Read the preparation and recurring invoice together. Likeness Rx offers online access to compounded semaglutide and tirzepatide. Its public page lists semaglutide from $79/month; tirzepatide from $129/month.
The lowest monthly equivalents accompany 12-month subscriptions: $948 for semaglutide or $1,548 for tirzepatide. One-month plans are $139 and $199. The page says the selected term renews automatically; check the amount due and cancellation date.
The public site describes licensed-provider review, shipping after approval and care-team messaging. Those are service statements rather than measured response times.
These are provider-published terms checked October 4, 2026. Prescription approval is conditional. Compounded medications are not FDA-approved; we have not tested the treatment, pharmacy fulfillment or patient outcomes.
Product and subscription information checked at likenessrx.com on October 4, 2026.
4. SnagRx: a promotional floor with term rules
SnagRx describes a clinician-reviewed compounded supply with a patient portal for refills. Its marketing separates no-membership pricing from selected subscription discounts. The product and pharmacy remain individualized prescription facts, while its prominent promotional price needs a term and renewal check. The low promotion is worth understanding, but term discounts and medically limited refunds matter alongside it. Confirm whether the selected checkout is monthly or subscribe-and-save, and what charge follows the current promotional offer.
SnagRx currently promotes compounded semaglutide at $69 and tirzepatide at $119 per month, with medication, supplies, doctor review and free shipping described as included. It distinguishes month-to-month cancellation from subscribe-and-save term discounts. Sales are generally final, with unused-term refunds tied to medical ineligibility. Confirm promotion eligibility, selected term, quantity and renewal before treating the floor as guaranteed indefinitely.
Read the full SnagRx review to compare the care pathway, prescription and recurring order.
SnagRx: compare the selected agreement with the questions in this section.
5. AltRx: a bundled GLP-1 pathway
AltRx’s self-pay pathway includes a medical review and pharmacy fulfillment when appropriate. The page names independently operated pharmacy partners and distinguishes its compounded offers from branded product listings. A low promotional rate does not establish equivalent outcomes or FDA approval of the compounded preparation. The page distinguishes GLP-1 from GLP-1 plus GIP and branded products. Ask which actual preparation the lower offer concerns and retain its clinical and fulfillment inclusion instead of borrowing a price across categories.
AltRx currently displays a GLP-1 offer from $89 per month and GLP-1 plus GIP from $149, with separate branded product prices. Its membership includes consultation, prescription fulfillment when appropriate, shipping and clinician support; no separate membership fee is advertised. Confirm the actual compound, dispensed quantity and recurring terms. Self-reported member outcomes are not independent clinical evidence.
Read the full AltRx review to compare the care pathway, prescription and recurring order.
6. Enhance.MD: a first price and later four-week rate
Enhance.MD connects clinician-directed compounded programs with a four-week supply, support and stated laboratory inclusion. Its semaglutide and tirzepatide offers have separate introductory and later prices. The different program names and supply periods should remain visible when the ongoing care budget is compared. The initial semaglutide price is materially lower than the ongoing figure. Both should stay visible, with the four-week supply unit preserved so a long-term budget does not mistake the first charge for the regular plan.
The dated Enhance.MD update records the observed introductory and continuing cards and their supply period. Confirm shipment, subscription and supply terms: four weeks is not a calendar month, and a low initial charge is not the ongoing budget.
7. Trimi: monthly payment versus annual equivalent
Trimi describes individualized compounded semaglutide and tirzepatide prescriptions with provider review, supplies and shipment. It offers materially different annual and monthly payment commitments. The named pharmacy pathway helps identify what to ask, while regulatory status and clinical rationale still need separate consideration. The annual plan’s low equivalent requires a much larger upfront commitment. Compare that cash requirement with the monthly option, not just the unit number, especially when a first prescription’s tolerance and continuity remain uncertain.
Trimi’s current compounded semaglutide choices are $175 month-to-month or a $99 monthly equivalent on a twelve-month commitment billed $1,188 upfront. Tirzepatide is $235 monthly or $125 equivalent with $1,500 upfront. It lists provider review, supplies and shipping with no membership fee. Confirm selected term, actual amount supplied and refund rules; the annual equivalent is not a monthly payment.
Read the full Trimi review to compare the care pathway, prescription and recurring order.
Choose the next step, then confirm the order
Obtain a complete quotation for the actual prescription and supply before calling any plan the cheapest for the patient. A lower first bill, smaller unit price and lower yearly equivalent answer different questions. Keep cancellation and refund terms visible, particularly before a prescription is prepared.
FDA cautions that compounded GLP-1 products are not approved and that dosing errors and product-quality concerns have been reported. Do not transfer instructions between vials or use an internet syringe conversion. The pharmacist and prescriber should resolve an unclear label before use.
Original references are retained below. Later observations and their source dates are identified in the dated updates and research notes. Advertising describes an offer; it is not independent verification of treatment outcomes.